AGP Executive Report
Last update: 8 hours agoChina–Pakistan Health Tech: China and Pakistan unveiled a Zhejiang-Pakistan joint lab for herbal medicine R&D, aiming to deepen traditional medicine cooperation. Regulatory Milestone: Pakistan secured observer status at ICH, a step meant to modernize DRAP and align standards with global regulators. HIV Prevention Breakthrough: South Africa officially launched the twice-yearly injectable HIV prevention rollout of lenacapavir, backed by major Global Fund and CIFF funding. Cancer & Drug Policy: A U.S. Supreme Court ruling backed Hikma in a “skinny label” patent dispute over generic Vascepa, while a Los Angeles jury sided with J&J in a talc ovarian cancer case. Public Health Watch: India reported suspected Ebola in Jaipur with tests pending, and Argentina expanded its hantavirus outbreak investigation after a cruise-linked cluster. Care Access & Systems: Santa Clara County leaders urged state funding to protect public hospitals from looming federal cuts. Diabetes Prevention Tech: An EHR-based machine learning model flagged adults at high type 2 diabetes risk up to 10 years ahead.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.